Capital increase in IDEX registered

The extraordinary general meeting of shareholders in IDEX ASA on 29 January 2014 resolved a private placement of 60,000,000 shares and issue of 30,000,000 warrants in IDEX ASA to funds managed by Invesco Asset Management Limited.

The share capital increase has been registered in the Norwegian Register of Business Enterprises, and the shares will be issued as soon as practical after the prospectus prepared in connection with the private placement of shares has been approved and disclosed.

Following the registration, the company’s share capital will be NOK 60,706,159.80 divided into 404,707,732 registered shares each with a nominal value of NOK 0.15. There will be 30,000,000 warrants and 28,756,345 incentive subscription rights outstanding.

4 February 2014
IDEX ASA

Web: www.idexbiometrics.com 
Twitter: http://www.twitter.com/idexasa
LinkedIn: http://www.linkedin.com/company/idex-asa 

Contact: Erling Svela, CFO,  +47 4062 1040,  erling.svela(at)idexbiometrics.com

About IDEX
IDEX ASA specialises in fingerprint imaging and recognition technology. IDEX’s vision is to ensure individuals a safe, secure, and user-friendly use of personal ID. IDEX has developed the award-winning SmartFinger technology platform based on the Company’s core intellectual property, including the patented fingerprint imaging principle, sensing scheme and chip design. Combined with core software solutions for imaging and authentication, the SmartFinger technology enables on-device enrollment, template storage and verification within the very same module. SmartFinger solutions can be seamlessly integrated into a variety of embedded applications such as mobile phones, one-time password devices, Smartcards, payment and ID cards, payment terminals, access control devices and biometric security and login tokens.

IDEX ASA (ticker IDEX) is a Norwegian public company listed at the Oslo Axess marketplace on the Oslo Børs (Oslo stock exchange). For more information, please visit www.idexbiometrics.com or contact IDEX at mailbox@idexbiometrics.com

–o–

 
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

FACEBOOK
GOOGLE
TWITTER
LINKEDIN